Biomea Fusion, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$83.5M | -$144.1M | -$126.1M | -$83.6M | -$41.7M |
| Operating expenses | $83.5M | $144.1M | $126.1M | $83.6M | $41.7M |
| Cash from operations | -$70.4M | -$119.9M | -$96.6M | -$62.4M | -$35.4M |
| Capital expenditure | — | $362,000 | $3.4M | $1.0M | $3.2M |
| Free cash flow | — | -$120.3M | -$100.0M | -$63.4M | -$38.6M |
| Impairments | $2.2M | $0 | $0 | — | — |
| Total assets | $58.6M | $79.9M | $199.9M | $129.3M | $185.7M |
| Total liabilities | $29.0M | $28.4M | $30.7M | $20.8M | $6.9M |
Shares outstanding 72.3M · Free float 75.2%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.